+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Tissue digoxin concentrations at digoxin intoxication in normal, acutely hypokalemic, and acutely hyperglycemic dogs



Tissue digoxin concentrations at digoxin intoxication in normal, acutely hypokalemic, and acutely hyperglycemic dogs



Physiological Chemistry and Physics 8(3): 207-220



Thirty intact dogs were studied to determine digoxin concentration in various tissues after ventricular tachycardia had been induced by digoxin infusion. A control group was infused solely with digoxin. A second group was made acutely hypokalemic by glucose-insulin infusion before the digoxin infusion. A third group was infused with glucose and digoxin to determine the effect of increased blood glucose levels and osmalarity on the induction of ventricular tachycardia. Results were: (1) The amount of digoxin infused to produce ventricular tachycardia did not differ getween the normal and hypokalemic groups. (2) The concentration of digoxin in various parts of the heart, other muscle tissue, renal cortex, and liver did not differ between the normal and acutely hypokalemic dogs although the amount excreted in bile and urine was reduced in hypokalemia. (3) Acute hypokalemia did not sensitize the myocardium to the arrhythmogenic effects of digoxin. (4) Ventricular tachcardia occurred at a similar plasma digoxin level in normal and acutely hypokalemic dogs. (5) In dogs with a lowered plasma potassium level, junctional tachycardia occurred whereas it did not occur in normal dogs or those with only a high blood glucose level. (6) Ventricular tachycardia occurred in the hyperglycemic dogs at a plasma digoxin level of 170 ng/ml, which was significantly greater than in the other experiments (7) Acute hyperglycemia reduced the mean rate of myocaridal uptake of digoxin into atria and right and left ventricular tissue; and the concentration of digoxin in atria, left ventricle, and interventricular septum was lower at the time of ventricular tachycardia than occurred in normal dogs. (8) Lowering the plasma potassium level in the presence of acute hyperglycemia, which occurred with the glucose-insulin infusion, did increase the myocardial uptake of digoxin. Similar effects of hyperglycemia were noted on mean hepatic uptake and excretion of digoxin and also the renal uptake of the glycoside.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041813560

Download citation: RISBibTeXText

PMID: 1013176


Related references

The distribution of 3H-digoxin in normal and acutely hyperkalaemic dogs. Cardiovascular Research 4(2): 235-241, 1970

Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations. American Journal of Clinical Pathology 111(3): 406-410, 1999

Tissue digoxin concentrations and digoxin effect during the quinidine-digoxin interaction. Journal of the American College of Cardiology 5(3): 680-686, 1985

Clinical studies on digoxin intoxication 2. relationship between plasma and erythrocyte digoxin concentrations. Japanese Heart Journal 21(4): 497-504, 1980

Relationship between digoxin plasma concentrations and frequency of digoxin intoxication. Arzneimittel-Forschung 31(9): 1469-1471, 1981

The diagnostic value of determination of intraerythrocytic sodium and potassium concentrations versus plasma digoxin concentration in digoxin intoxication. Acta Medica Scandinavica 213(5): 357-362, 1983

Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication. European Journal of Clinical Pharmacology 30(5): 527-533, 1986

Estimating concentrations of total digoxin and digoxin-like immunoreactive substances in volume-expanded patients being treated with digoxin. Therapeutic Drug Monitoring 18(1): 34-39, 1996

Determination of free serum digoxin concentrations in digoxin toxic patients after administration of digoxin fab antibodies. Therapeutic Drug Monitoring 14(2): 147-154, 1992

Monitoring free digoxin instead of total digoxin in patients with congestive heart failure and high concentrations of digoxin-like immunoreactive substances. Clinical Chemistry 36(12): 2121-2123, 1990

The effect of insulin and glucose on the myo cardial and skeletal muscle uptake of tritiated digoxin in acutely hypo kalemic and normo kalemic dogs. Journal of Pharmacology and Experimental Therapeutics 188(3): 564-574, 1974

Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin. Annals of Clinical Research 5(2): 87-90, 1973

The electrophysiologic effects of low and high digoxin concentrations on isolated mammalian cardiac tissue: reversal by digoxin-specific antibody. Journal of Clinical Investigation 51(6): 1378-1387, 1972

Tissue digoxin concentrations during the quinidine digoxin interaction. American Journal of Cardiology 51(10): 1717-1721, 1983

Digoxin and a clinical evaluation of three digoxin methods, microgenic CEDIA Digoxin Plus, Dade Stratus digoxin and Technicon Immuno 1. Clinical Chemistry 40(6): 1082, 1994